Robinswood Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Hold
66
﹤0.01% 288
2026
Q1
$10.1K Hold
66
﹤0.01% 276
2025
Q4
$9.1K Hold
66
﹤0.01% 272
2025
Q3
$8.46K Hold
66
﹤0.01% 267
2025
Q2
$7.99K Hold
66
﹤0.01% 267
2025
Q1
$7.36K Hold
66
﹤0.01% 267
2024
Q4
$6.42K Hold
66
﹤0.01% 230
2024
Q3
$7.59K Buy
+66
New +$7.49K ﹤0.01% 230

Other funds holding NVS

Robinswood Financial's NVS Position: Q2 2026 in Review

Robinswood Financial held its Novartis (NVS) position steady in Q2 2026 at 66 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Robinswood Financial first reported a position in NVS in Q3 2024 and has held it in 8 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Robinswood Financial held 66 shares of Novartis worth $10.3K as of Q2 2026.
  • Robinswood Financial left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Robinswood Financial's portfolio in Q2 2026, its #288 holding.
  • Robinswood Financial first reported a position in Novartis in Q3 2024 and has held it in 8 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.